Sarepta Therapeutics, Inc. — Director's Dealing 2016

Nov 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2016-11-09

Reporting Person: Kaye Edward M. MD (Director, President, CEO & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-09	Common Stock	M	3000	$8.28	Acquired	75635	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-09	Incentive Stock Option (right to buy)	$8.28	M	3000	Disposed	2021-06-20	Common Stock (3000)	Direct

Footnotes

F1: This option became exercisable at the rate of 25% of the shares on June 20, 2012 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option became fully exercisable on June 20, 2015.